Perpetuals.com Expands AI Technology from Finance to Healthcare with New Clinical Diagnostic Platform

Perpetuals.com Ltd. (NASDAQ: PDC) announced the expansion of its BayesShield AI technology into healthcare with the launch of BayesShield Clinical, designed to identify physicians with the strongest diagnostic accuracy across specific case types. The platform applies the company's statistical methodology, originally developed for financial markets, to reduce bias and improve clinical decision-making. This represents a significant cross-industry application of AI technology initially created for trading and risk assessment.

The initial deployment of BayesShield Clinical is supported through a partnership with the European Institute of Management to oversee pilot programs and academic validation. This collaboration aims to ensure the platform's effectiveness and reliability in clinical settings before broader implementation. The company's proprietary trading platform, Kronos X, combines advanced AI and data analysis, trained on billions of trades, monitors market activity in real time, identifies patterns for trading and risk decisions, and provides multi-asset coverage with self-clearing blockchain-based settlement.

Perpetuals.com Ltd. is a fintech company developing AI-powered trading products and prediction markets, with a global footprint across the United States, Europe, and Asia. The company's mission is to reduce risk through empowering retail users with intuitive, secure, and efficient trading experiences across multiple asset classes. The company is extending its AI methodology to healthcare and other decision-intensive domains through BayesShield. The company's licensed European Multilateral Trading Facility (MTF) infrastructure and Kronos X multi-asset exchange platform operate with full MiFID II, MiCA, DORA, and EMIR compliance.

The expansion into healthcare represents a strategic diversification for the fintech company, leveraging its existing AI infrastructure to address challenges in medical diagnostics. By applying statistical methods proven in financial contexts to healthcare decision-making, the company aims to bring greater objectivity and accuracy to clinical assessments. The latest news and updates relating to PDC are available in the company's newsroom at https://ibn.fm/PDC. For more information about AINewsWire, please visit https://www.AINewsWire.com.